Voloridge Investment Management, LLC Crispr Therapeutics Ag Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 166,263 shares of CRSP stock, worth $6.75 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

166,263

Holding current value

$6.75 Million

% of portfolio

0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$44.62 - $62.75 $7.42 Million - $10.4 Million	166,263 New	166,263 $7.81 Million
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $41.4 Million - $60.8 Million	-682,575 Reduced 93.9%	44,312 $3.02 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $28.1 Million - $52.5 Million	726,887 New	726,887 $45.5 Million
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $1.76 Million - $2.74 Million	-40,482 Reduced 61.22%	25,642 $1.44 Million
Q1 2023 May 15, 2023	BUY	$41.0 - $56.12 $2.71 Million - $3.71 Million	66,124 New	66,124 $2.99 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $8.11 Million - $11.1 Million	-132,710 Reduced 89.61%	15,380 $1.01 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $9.99 Million - $17.1 Million	-231,144 Reduced 60.95%	148,090 $9 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $8.7 Million - $13 Million	163,605 Added 75.87%	379,234 $23.8 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $14.9 Million - $23.7 Million	212,906 Added 7818.8%	215,629 $16.3 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $204,972 - $291,350	-1,860 Reduced 40.58%	2,723 $305,000
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $3.7 Million - $5.94 Million	-36,676 Reduced 88.89%	4,583 $742,000
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $1.34 Million - $2.53 Million	12,068 Added 41.34%	41,259 $5.03 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $2.33 Million - $5.06 Million	29,191 New	29,191 $4.47 Million
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $2.01 Million - $3.73 Million	-59,617 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $2.19 Million - $4.36 Million	59,617 New	59,617 $3.63 Million
Q1 2019 May 15, 2019	SELL	$28.02 - $40.87 $1.75 Million - $2.56 Million	-62,580 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $1.42 Million - $2.65 Million	62,580 New	62,580 $1.79 Million

Others Institutions Holding CRSP

# of Institutions

486

Shares Held

58.9M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.17B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Crispr Therapeutics Ag Transaction History